{"news_desk": "SundayBusiness", "print_page": "1", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By GRETCHEN MORGENSON", "person": [{"rank": 1, "role": "reported", "firstname": "Gretchen", "organization": "", "lastname": "MORGENSON"}]}, "abstract": "Gretchen Morgenson Fair Game column says J Kyle Bass and Erich Spangenberg, through their Coalition for Affordable Drugs, are taking on pharmaceutical patents they view as dubious or abusive; points out they want to lower drug prices that are kept artificially high.", "type_of_material": "News", "word_count": "1438", "lead_paragraph": "The Coalition for Affordable Drugs goes after pharmaceutical companies that it says exploit the patent system to keep prices and profits high.", "pub_date": "2015-11-29T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Working to Lower Drug Costs by Challenging Questionable Patents", "content_kicker": "Fair Game", "print_headline": "Paying More for Zombies in the Pillbox", "kicker": "Fair Game"}, "snippet": "The Coalition for Affordable Drugs goes after pharmaceutical companies that it says exploit the patent system to keep prices and profits high.", "multimedia": [{"height": 126, "url": "images/2015/11/29/business/29-GRET-JP/29-GRET-JP-thumbWide-v2.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/11/29/business/29-GRET-JP/29-GRET-JP-thumbWide-v2.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 489, "url": "images/2015/11/29/business/29-GRET-JP/29-GRET-JP-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "489", "xlarge": "images/2015/11/29/business/29-GRET-JP/29-GRET-JP-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/11/29/business/29-GRET-JP/29-GRET-JP-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/11/29/business/29-GRET-JP/29-GRET-JP-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/11/29/business/working-to-lower-drug-costs-by-challenging-questionable-patents.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Bass, J Kyle", "name": "persons"}, {"rank": "2", "is_major": "Y", "value": "Spangenberg, Erich", "name": "persons"}, {"rank": "3", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Celgene Corporation", "name": "organizations"}, {"rank": "5", "is_major": "N", "value": "Inventions and Patents", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Hayman Capital Management LP", "name": "organizations"}, {"rank": "7", "is_major": "N", "value": "IP Navigation Group LLC", "name": "organizations"}, {"rank": "8", "is_major": "N", "value": "Patent and Trademark Office (US)", "name": "organizations"}, {"rank": "9", "is_major": "N", "value": "Shire PLC", "name": "organizations"}], "blog": [], "_id": "5658967238f0d86d6ede458d", "source": "The New York Times"}